Condition: Endometrial Carcinoma Stage I · Atypical Endometrial Hyperplasia · Sponsor: Peking University People's Hospital
To construct a prediction model of progesterone sensitivity in patients with endometrial cancer treated with fertility preservation
This description comes directly from the study's public registry record.
WANG JIANLIU, PhD/MD · 8601088324383 · wangjianliu1203@163.com
HE YIJIAO, PhD · +8618301512017 · heyijiao2017@pku.edu.cn
Always discuss trial participation with your own doctor first.
| Peking University People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05647109